4//SEC Filing
DeSieno Alexis 4
Accession 0001666071-25-000071
CIK 0001666071other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:03 PM ET
Size
9.3 KB
Accession
0001666071-25-000071
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
DeSieno Alexis
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-05-14+43,750→ 191,050 total - Sale
Common Stock
2025-05-15$1.94/sh−26,217$50,809→ 164,833 total - Exercise/Conversion
Restricted Stock Units
2025-05-14−43,750→ 43,750 total→ Common Stock (43,750 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F2]Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on May 14, 2025. The Reporting Person did not sell shares for any other purpose.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.88 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- [F4]The RSU award was originally for 350,000 shares. 50% of the RSUs vested on August 14, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over the one year period following the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001987391
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:03 PM ET
- Size
- 9.3 KB